The Verastem stock price fell by -66.17% on the last day (Friday, 24th May 2024) from $12.18 to $4.12. During the last trading day the stock fluctuated 30.60% from a day low at $4.02 to a day high of $5.25. The price has been going up and down for this period, and there has been a -65.23% loss for the last 2 weeks.Track Versus Systems Inc (VS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients ...Also, please be aware that the security and privacy policies on these sites may be different than Verastem Oncology policies, so please read third party privacy and security policies closely. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.BOSTON, January 29, 2024--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today outlined key 2024 strategic priorities ...Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer. BOSTON, April 18, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of John Hayslip, M.D., an accomplished oncologist with deep clinical research, development, and commercialization experience ...Verastem Oncology is currently conducting clinical trials with its RAF/MEK clamp avutometinib in RAS/MAPK driven tumors as part of its (Raf And Mek Program). RAMP 301 (NCT06072781) is a Phase 3 confirmatory trial evaluating the combination of avutometinib and defactinib versus standard chemotherapy or hormonal therapy for the …Track SeaStar Medical Holding Corp (ICU) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsJoined 1/2015. 10 Following 54.4k Followers. Posts. The latest messages and market ideas from Jared Wesley (@ScalpMaster) on Stocktwits. 18 year professional trader enjoying the perks and lifestyle this business affords. [email protected](BUSINESS WIRE)--Jun. 22, 2020-- Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced results from a study that provides preclinical proof-of-concept for …VSTM on Twitter. Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote …VSTM Stock 12 Months Forecast. $31.67. (187.91% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Verastem in the last 3 months. The average price target is $31.67 with a high forecast of $36.00 and a low forecast of $27.00. The average price target represents a 187.91% change from the last price of $11.00.See the latest Verastem Inc stock price (VSTM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Track ImmunityBio Inc (IBRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Trading Up 2.5 %. Shares of NASDAQ:VSTM opened at $12.18 on Friday. The business’s 50-day moving average is $11.25 and its 200 day moving average is $10.20. Verastem has a 1 year low of ...We would like to show you a description here but the site won’t allow us.Track Veritone Inc (VERI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Iovance Biotherapeutics Inc (IOVA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMar 14, 2024 · BOSTON, March 14, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three ...2 days ago · Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer ...Verastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019–)Track Visium Technologies Inc (VISM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsA high-level overview of Verastem, Inc. (VSTM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Track Cassava Sciences Inc (SAVA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem's pipeline is poised to produce major catalysts over the next two years similar to the move produced by the Duvelisib + FCR data read out in June at EHA. ... charts.stocktwits.com ...BBG001J2LSK5. Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered ...Inside Verastem, Inc.'s 10-K Annual Report: Other - Other Highlight. For example, if the FDA or other regulatory authority were to require us to conduct clinical trials beyond those which we currently anticipate will be required for the completion of clinical development of a product candidate or if we experience significant delays in enrollment in any clinical trials, we could be required to ...Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways.Get the latest Verastem Inc (VSTM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Track Virios Therapeutics Inc (VIRI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAs previously announced, Verastem Oncology plans to file for accelerated approval with the FDA for the combination of avutometinib and defactinib based on mature data from the RAMP 201 trial ...Track Roivant Sciences Ltd (ROIV) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Sabre Corp (SABR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsKey Events. Mountain. Loading Chart for VSTM. 9/21 12:03 PM. Previous Close 12.1800. Open 4.7300. Bid 4.0500 x 700. Ask 5.1500 x 200. Day's Range 4.0200 - 5.2500. 52 …Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition.BOSTON, January 18, 2024--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the U.S. Food and Drug ...Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer ...BOSTON--(BUSINESS WIRE)--Jun. 16, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 7,181,409 shares of its common stock at a price to the public of $9.75 per share and, in …Verastem Oncology is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accurary of the information contained in the linked sites. We suggest that you always verify the information obtained ...Track GSE Systems, Inc. (GVP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsInvestigational New Drug (IND) Submission Planned for GFH375/VS-7375 in H1 2024No FDA Approved Therapies Available Targeting KRAS G12D, the Most Prevalent KRAS Mutation in Human CancerBOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to …Track Trump Media & Technology Group Corp. (DJT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival …Verastem Oncology is also supporting an investigator-initiated Phase 2 trial evaluating VS-6766 with defactinib in patients with metastatic uveal melanoma. Verastem Oncology has initiated Phase 2 registration-directed trials of VS-6766 with defactinib in patients with recurrent LGSOC and in patients with recurrent KRAS-G12V mutant …Verastem Oncology is headquartered at 117 Kendrick Street, Suite 500, Needham, MA 02494, U.S. The main phone number is 781-292-4200.The detail page will show you the real-time trend, you can click into the MSN Money website for more detailsShares of Verastem, Inc. (NASDAQ:VSTM - Get Free Report) have been assigned an average recommendation of "Buy" from the six brokerages that are covering the firm, Marketbeat.com reports.Six investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $28.79.Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed ...Track Palantir Technologies Inc (PLTR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Castor Maritime Inc (CTRM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology is currently conducting clinical trials with its RAF/MEK clamp avutometinib in RAS pathway-driven tumors as part of its Raf And Mek Program (RAMP). RAMP 301 is a Phase 3 ...The consensus estimate for Verastem's current full-year earnings is ($4.31) per share. B. Riley also issued estimates for Verastem's FY2028 earnings at $2.37 EPS. Several other research firms ...GFH375/VS-7375. GFH375/VS-7375 is an orally bioavailable, potent and selective small molecule KRAS G12D (ON/OFF) inhibitor. Preclinical models demonstrate strong tumor regression as a single agent and support approaches in combination with Verastem Oncology’s RAF/MEK clamp avutometinib as well as other rational combinations across KRAS G12D ...BOSTON--(BUSINESS WIRE)--Jun. 16, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 7,181,409 shares of its common stock at a price to the public of $9.75 per share and, in …Track Altimmune Inc (ALT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFind the latest Karyopharm Therapeutics Inc. (KPTI) stock quote, history, news and other vital information to help you with your stock trading and investing.Snacking, tasting, sampling, and eating more than you'd care to admit — just because — is common. There are practical things you can do to help yourself. When the urge to eat arise...BOSTON--(BUSINESS WIRE)--Apr. 4, 2024-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 35,000 shares of its common stock to four new employees.The awards were granted pursuant to the Nasdaq inducement grant exception as an inducement material to the employees ...Verastem . Hey, anyone have any strong feelings one way or the other on Verastem? I've been holding a while and just can't find much info, but then again I could just be bad at the research at this point. ... I advise you to research it and check it out on StockTwits. Super active board!Verastem Oncology, Inc. (NASDAQ: VSTM), is a biopharmaceutical company headquartered in Needham, MA. The focus of our research is developing a portfolio of novel small molecule drugs that inhibit critical RAS signaling pathways that promote cancer cell survival and tumor growth. To learn more about our research program, as well as the details ...Track Candel Therapeutics Inc (CADL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Rail Vision Ltd (RVSN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem, Inc. Brian Sullivan, 781-292-4214 Director, Corporate Development [email protected] or Infinity Pharmaceuticals, Inc. Jaren Irene Madden, 617-453-1336 Senior Director, Investor Relations and Corporate Communications [email protected]. E-mail Alerts. You may automatically receive Verastem Oncology financial information by e ...Newly Issued Patents Extend Coverage of VS-6766 and VS-6766 + Defactinib to 2038 and 2040. BOSTON -- (BUSINESS WIRE)--Oct. 4, 2022-- Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced an update on its RAMP ( R af A nd M ek P rogram) clinical trials.Investors: Dan Calkins +1 781-469-1694 Investor Relations [email protected] Ryan Porter +1 212-600-1902 [email protected] Media: Lisa Buffington Corporate Communications +1 781-292 ...Track T2 Biosystems Inc (TTOO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Verastem Inc (VSTM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Verastem to Seek FDA Accelerated Approval, Pending Trial Outcome . BOSTON--(BUSINESS WIRE)--Nov. 30, 2020-- Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the initiation of a Phase 2 registration-directed clinical ...Verastem Oncology | 13,729 followers on LinkedIn. Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a late-stage development biopharmaceutical company committed to the development and ...Comparatively, 88.4% of Verastem shares are held by institutional investors. 3.8% of Akebia Therapeutics shares are held by insiders. Comparatively, 2.2% of Verastem shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.Verastem Inc • Biotechnology Thu 16 May, close Current 1 day ago 2 days ago 3 days ago 4 days ago 5 days ago 6 days ago 7 days ago 8 days ago 9 days ago 10 days ago 11 days ago 12 days ago 13 days ago 14 days ago 15 days ago 16 days ago 17 days ago 18 days ago 19 days ago 20 days ago 21 days ago 22 days ago 23 days ago 24 days ago 25 days agoAt Verastem Oncology, we're on a mission to make sure no patient ever has to hear that news. We embrace the power of partnership and collaboration to develop novel cancer therapies. It's through these collaborations that we'll bring hope to patients with RAS pathway-driven cancers. Purposeful. Unwavering. Influential. Insightful.Track Aeva Technologies Inc (AEVA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsReminiscent of a favorite grilled steak from a local Chinese restaurant, this burger is for ginger lovers. Do not substitute dried ginger for the fresh: unless you are baking, drie...Some Amazon staff began distributing Slack and email messages on Monday calling for other workers to join the protest, The Washington Post reported. Jump to Some Amazon employees i.... Free VSTM Stock Alerts. $11.50. -0.63 (-5.19%) (Verastem Oncology (Nasdaq: VSTM) is a development-sta How much is Verastem stock worth today? ( NASDAQ: VSTM) Verastem currently has 25,325,551 outstanding shares. With Verastem stock trading at $11.61 per share, the total value of Verastem stock (market capitalization) is $294.03M. Verastem stock was originally listed at a price of $133.08 in Jan 27, 2012.Verastem (NASDAQ: VSTM) just reported results for the fourth quarter of 2023. Verastem reported earnings per share of -$1.10. This was below the analyst estimate for EPS of -62 cents. The company ... Track Marathon Digital Holdings Inc (MARA) Stock Price, Quote, latest Feb 2, 2023 · On January 24, 2023, Verastem Oncology announced that it had entered into a definitive agreement to sell up to approximately 2.1 million shares of Preferred Stock to affiliates of BVF Partners L.P. in a private placement to raise aggregate gross proceeds of up to approximately $60 million in two tranches, before deducting fees to the placement ... GFH375/VS-7375. GFH375/VS-7375 is an orally bioavailable, potent and s...
Continue Reading